Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection
Patients undergo first doses of GE HealthCare's PET radiotracer Flyrcado (flurpiridaz F 18) injection at early adopter sites ...
GE HealthCare announces first patient doses of Flyrcado for CAD detection
GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...
Hosted on MSN2d
GE HealthCare delivers first PET MPI agent doses for CAD detection
GE HealthCare has delivered the initial subject doses of a positron emission tomography (PET) myocardial perfusion imaging ...
GE HealthCare projects $4.61-$4.75 adjusted EPS for 2025 amid margin expansion and Flyrcado launch
Discover GE HealthCare's Q4 2024 insights: record $19.8B backlog, 18.7% margin growth, and Flyrcado's 2025 launch.
Investing24d
GE HealthCare Technologies Inc (GEHC)
ARLINGTON HEIGHTS, Ill. - GE HealthCare (NASDAQ: NASDAQ:GEHC) has received U.S. Food and Drug Administration (FDA) approval for Flyrcado™ (flurpiridaz F 18) injection, a new... ByInvesting.com ...
Morningstar3d
Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection
GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion ...